Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oak Ridge National Laboratory

www.ornl.gov

Latest From Oak Ridge National Laboratory

Recent Financings of Private Companies (09/11)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

NellOne Therapeutics Inc.

NellOne Therapeutics Inc. believes it can help patients restore muscle mass and function thanks to a gene called Nell-1. If early studies bear out, the company’s research could yield protein therapeutics capable of regenerating muscle around joint replacements and even in hearts damaged by heart attacks. An in vitro study of heart muscle cells showed the protein could protect those cells and prevent them from dying in the very kind of low-oxygen situation that typifi es the conditions that heart muscle cells encounter during a heart attack. NellOne has chosen to develop its technology as a wound-healing therapy initially, because that research is farthest along and the path to market is shorter than for a cardiovascular indication.
BioPharmaceutical Regenerative Medicine

Recent Financings of Private Companies (07/2008)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Robotics: Moving Surgery into the Information Age

Robotic surgery systems represent one of the fastest growing segments of the overall endoscopic surgery products market. These technologies allow surgeons to perform complex microsurgical tasks with greater precision and smaller incisions, thereby improving cosmesis, reducing postoperative pain, and shortening the length of hospital stay.
Medical Device Platform Technologies
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register